Complete regression of metastatic tumors of the adult with antimitotic treatment
| Autor: | E Pommatau, H Mayer, Dargent M, Brunat M |
|---|---|
| Rok vydání: | 1974 |
| Předmět: |
Adult
Male Oncology medicine.medical_specialty Lung Neoplasms Adolescent Cyclophosphamide medicine.medical_treatment Hemangiosarcoma Antineoplastic Agents Vinblastine Metastatic carcinoma Testicular Neoplasms Pregnancy Internal medicine medicine Humans Choriocarcinoma Mechlorethamine Thyroid Neoplasms Neoplasm Metastasis Chemotherapy Epithelioma Mercaptopurine business.industry Teratoma Infant Prostatic Neoplasms Sarcoma General Medicine Middle Aged Thoracic Neoplasms medicine.disease Methotrexate Head and Neck Neoplasms Uterine Neoplasms Dactinomycin Female Triaziquone Surgery business Follow-Up Studies medicine.drug |
| Zdroj: | Journal of Surgical Oncology. 6:49-59 |
| ISSN: | 1096-9098 0022-4790 |
| DOI: | 10.1002/jso.2930060107 |
| Popis: | We have presented 7 patients in whom metastatic carcinoma regressed by chemotherapy alone. They are well without evidence of disease for 5 to 10 years. The patients include 4 embryonal carcinoma of the testis, 1 uterine chorioepithelioma, 1 prostatic sarcoma, and 1 trabeculo-follicular epithelioma of the thyroid. They received 1 or more courses of chemotherapy (trenimon or nitromin alone, or triple association actinomycin D, methotrexate, and cytoxan). We cannot explain why these are apparently cured and why others, treated with the same drugs, had no regression at all. No immunological studies were done. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text